医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Focus on International Cooperation for Global Access to Vaccines at the DCVMN 16th Annual AGM.

2015年10月07日 AM10:40
このエントリーをはてなブックマークに追加


 

BANGKOK

Under the auspices of the Queen Saovabha Memorial Institute (QSMI) of the Thai Red Cross Society and BioNet-Asia, the 16th Annual General Meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) kicked off this week in Bangkok, Thailand.

Mr. Phan Wannamethee, Secretary General of the Thai Red Cross Society, opened the conference by reminding that “The DCVMN’s ultimate goal is in harmony with the philosophy of the Thai Red Cross Society in the relief of disasters, promotion of welfare, and elimination of diseases.” He then “commended members of DCVMN for their efforts to reach the common goal of protecting people against infectious diseases with better vaccines for a better quality of life.”

The conference includes key lectures and sessions with organizations like UNICEF, PAHO, VPPAG and IAIM. Dr. Jean-Marie Okwo-Bele, Director of WHO‘s Department of Immunization, Vaccines and Biologicals presented the Global Vaccine Action Plan (GVAP) and fascinating data on the progresses achieved, as well as the gaps and challenges ahead to attain these goals. Dr. Okwo-Bele explained how WHO helps accelerate research that will lead to vaccine licensure and vaccine policy and indicated that: “WHO convenes the best experts in the world to look at vaccines that are available, and to look at the evidence around those vaccines so we can understand how these vaccines can be used in developing countries”.

Several other key organizations such as CHAI, PATH and BMGF are also well represented at the conference. Dr. Peter Khoury, Senior Program Officer, The Bill & Melinda Gates Foundation indicated that: “The Gates Foundation supports research and development of vaccines particularly in developing countries, and it supports access to vaccines against preventable diseases for people in the poorest parts of the world. The basis for this belief is that all people deserve the chance to lead a healthy, productive life which is supported by DCVM’s supplying of high quality, low cost vaccines“.

About DCVMN

DCVMN is an international alliance of manufacturers aiming to protect people against known and emerging infectious diseases globally by increasing the availability and enhancing the quality of vaccines produced in emerging countries. www.dcvmn.org

About QSMI

The Queen Saovabha Memorial Institute of the Thai Red Cross Society is an institute producing BCG vaccine, equine Rabies Immunoglobulins and snake antivenoms. QSMI is also a World Health Organization Collaborating Center for research on Rabies and venomous snakes. www.saovabha.com

About BioNet

BioNet-Asia is a clinical-stage biotech company with a focus on technological innovation and global market access. The company is building up global partnerships, leading to the production of billions of doses of vaccines worldwide. www.bionet-asia.com

View source version on businesswire.com: http://www.businesswire.com/news/home/20151006007023/en/

CONTACT

BioNet-Asia Co., Ltd.
Mr. Supachai Nampornchaisakul, +66 2361 8110
info@bionet-asia.com
www.bionet-asia.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表
  • Intercell USA Changes Name to Valneva USA, Inc. and Expands Commercial Presence
  • ADC Therapeutics präsentiert Zwischenergebnisse aus Phase-I-Studie zu neuartigem Antikörper-Wirkstoff-Konjugat ADCT-402